ATA293589A - Neue chinolinsulfonaminoderivate und verfahren zu deren herstellung sowie pharmazeutische zusammensetzung - Google Patents

Neue chinolinsulfonaminoderivate und verfahren zu deren herstellung sowie pharmazeutische zusammensetzung

Info

Publication number
ATA293589A
ATA293589A AT0293589A AT293589A ATA293589A AT A293589 A ATA293589 A AT A293589A AT 0293589 A AT0293589 A AT 0293589A AT 293589 A AT293589 A AT 293589A AT A293589 A ATA293589 A AT A293589A
Authority
AT
Austria
Prior art keywords
chinolin
sulphon
new
production
pharmaceutical composition
Prior art date
Application number
AT0293589A
Other languages
English (en)
Other versions
AT398201B (de
Original Assignee
Hidaka Hiroyoshi
Tobishi Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hidaka Hiroyoshi, Tobishi Pharmaceutical Co filed Critical Hidaka Hiroyoshi
Publication of ATA293589A publication Critical patent/ATA293589A/de
Application granted granted Critical
Publication of AT398201B publication Critical patent/AT398201B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/10—Quaternary compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
AT0293589A 1988-12-26 1989-12-22 Neue chinolinsulfonaminoderivate und verfahren zu deren herstellung sowie pharmazeutische zusammensetzung AT398201B (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP32591088 1988-12-26
JP7641989 1989-03-30
JP8786889 1989-04-10

Publications (2)

Publication Number Publication Date
ATA293589A true ATA293589A (de) 1994-02-15
AT398201B AT398201B (de) 1994-10-25

Family

ID=27302151

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0293589A AT398201B (de) 1988-12-26 1989-12-22 Neue chinolinsulfonaminoderivate und verfahren zu deren herstellung sowie pharmazeutische zusammensetzung

Country Status (11)

Country Link
US (1) US5081246A (de)
KR (1) KR0183374B1 (de)
AT (1) AT398201B (de)
CA (1) CA2005741C (de)
CH (1) CH680441A5 (de)
DK (1) DK175678B1 (de)
ES (1) ES2029759A6 (de)
FR (1) FR2640973B1 (de)
GB (1) GB2228933B (de)
NL (1) NL193726C (de)
SE (1) SE503081C2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340811A (en) * 1990-03-08 1994-08-23 Asahi Kasei Kogyo Kabushiki Kaisha Isoquinoline-or quinoline-sulfonamide derivative and a pharmaceutical composition comprising the same
JPH069402A (ja) * 1991-05-15 1994-01-18 Hiroyoshi Hidaka 抗潰瘍剤
FR2679906B1 (fr) * 1991-07-31 1995-01-20 Adir Nouvelles (isoquinolein-5 yl) sulfonamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ES2084176T3 (es) * 1991-09-05 1996-05-01 Pharno Wedropharm Gmbh Derivados de sulfonamidas aromaticas, su uso como inhibidores de enzimas y composiciones farmaceuticas que los contienen.
US5378715A (en) * 1992-02-24 1995-01-03 Bristol-Myers Squibb Co. Sulfonamide endothelin antagonists
US5514696A (en) * 1992-05-06 1996-05-07 Bristol-Myers Squibb Co. Phenyl sulfonamide endothelin antagonists
US5420123A (en) * 1992-12-21 1995-05-30 Bristol-Myers Squibb Company Dibenzodiazepine endothelin antagonists
US5965732A (en) * 1993-08-30 1999-10-12 Bristol-Myers Squibb Co. Sulfonamide endothelin antagonists
US5612359A (en) * 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
US5780473A (en) * 1995-02-06 1998-07-14 Bristol-Myers Squibb Company Substituted biphenyl sulfonamide endothelin antagonists
US5760038A (en) * 1995-02-06 1998-06-02 Bristol-Myers Squibb Company Substituted biphenyl sulfonamide endothelin antagonists
US5846990A (en) * 1995-07-24 1998-12-08 Bristol-Myers Squibb Co. Substituted biphenyl isoxazole sulfonamides
JPH09124620A (ja) 1995-10-11 1997-05-13 Bristol Myers Squibb Co 置換ビフェニルスルホンアミドエンドセリン拮抗剤
US5856507A (en) * 1997-01-21 1999-01-05 Bristol-Myers Squibb Co. Methods for the preparation of biphenyl isoxazole sulfonamides
BR9708151A (pt) 1996-02-20 1999-07-27 Bristol Myers Squibb Co Processo para a preparaç o de bifenil isoxazol sulfonamidas
US5939446A (en) * 1996-04-09 1999-08-17 Bristol-Myers Squibb Co. Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists
TW536540B (en) * 1997-01-30 2003-06-11 Bristol Myers Squibb Co Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
AU6187898A (en) * 1997-01-30 1998-08-25 Bristol-Myers Squibb Company Method for preventing or treating low renin hypertension by administering an endothelin antagonist
IL125658A0 (en) 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
US6339087B1 (en) 1997-08-18 2002-01-15 Syntex (U.S.A.) Llc Cyclic amine derivatives-CCR-3 receptor antagonists
WO2000031033A1 (en) 1998-11-20 2000-06-02 F. Hoffmann-La Roche Ag Piperidine ccr-3 receptor antagonists
EP1165472A4 (de) 1999-03-19 2002-11-20 Bristol Myers Squibb Co Verfahren zur herstellung von biphenyl isoxazol
US6337326B1 (en) 1999-11-08 2002-01-08 American Home Products Corporation N-aryl-(homopiperazinyl)-cyclohexyl amines
US6639082B2 (en) 2000-10-17 2003-10-28 Bristol-Myers Squibb Company Methods for the preparation of biphenyl isoxazole sulfonamides
JP2005517684A (ja) * 2001-12-21 2005-06-16 キング ファーマシューティカルズ リサーチ アンド ディベロップメント インコーポレイテッド チロシル誘導体及びｐ２ｘ７受容体モジュレーターとしてのそれらの使用
AU2006285915B2 (en) * 2005-08-30 2011-02-24 Asahi Kasei Pharma Corporation Sulfonamide compound
GB0617222D0 (en) * 2006-08-31 2006-10-11 Vereniging Het Nl Kanker I Antibiotics
US8415372B2 (en) * 2007-02-27 2013-04-09 Asahi Kasei Pharma Corporation Sulfonamide compound
CN101622243B (zh) * 2007-02-28 2013-12-04 旭化成制药株式会社 磺酰胺衍生物
AU2008272396B2 (en) 2007-07-02 2011-09-08 Asahi Kasei Pharma Corporation Sulfonamide Compound and Crystal Thereof
NZ629855A (en) 2012-03-20 2016-01-29 Adamed Sp Zoo Sulphonamide derivatives of benzylamine for the treatment of cns diseases

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS609495B2 (ja) * 1976-02-18 1985-03-11 萬有製薬株式会社 ω−（アリ−ルスルホンアミド）−アルキルアミン
DD142804A3 (de) * 1977-11-07 1980-07-16 Wagner Guenter Verfahren zur herstellung von na-alkyl-bzw.na-aryl-sulfonylierten omega-amidinophenyl-alpha-aminoalkylcarbonsaeureamiden
US4456757A (en) * 1981-03-20 1984-06-26 Asahi Kasei Kogyo Kabushiki Kaisha Isoquinolinesulfonyl derivatives and process for the preparation thereof
SE8203887D0 (sv) * 1982-06-23 1982-06-23 Kabivitrum Ab Nya trombininhiberande foreningar
JPS5993054A (ja) * 1982-11-18 1984-05-29 Asahi Chem Ind Co Ltd イソキノリンスルホン酸アミド誘導体
JPS6081168A (ja) * 1983-10-13 1985-05-09 Asahi Chem Ind Co Ltd アミジン誘導体
US4678783B1 (en) * 1983-11-04 1995-04-04 Asahi Chemical Ind Substituted isoquinolinesulfonyl compounds
JPS61126026A (ja) * 1984-11-26 1986-06-13 Hiroyoshi Hidaka イソキノリンスルホン酸アミドを有効成分とする抗癌剤
EP0187371B1 (de) * 1984-12-27 1991-06-19 Asahi Kasei Kogyo Kabushiki Kaisha Substituierte Isochinolinsulfonyl-Verbindungen
JPS61271221A (ja) * 1985-05-28 1986-12-01 Hiroyoshi Hidaka ５−イソキノリンスルホニルピペラジンを有効成分とする抗癌剤
JPS61293914A (ja) * 1985-06-24 1986-12-24 Hiroyoshi Hidaka イソキノリン誘導体を有効成分とする抗癌剤
JPH062741B2 (ja) * 1985-10-29 1994-01-12 旭化成工業株式会社 ２級のイソキノリンスルホンアミド誘導体
JPH0667926B2 (ja) * 1985-11-12 1994-08-31 旭化成工業株式会社 環状のイソキノリンスルホンアミド誘導体
JPS6322757A (ja) * 1986-03-05 1988-01-30 Tokyo Tatsuno Co Ltd 自動車用サ−ビス装置
JPH0676384B2 (ja) * 1986-06-20 1994-09-28 旭化成工業株式会社 １−クロル−５−イソキノリンスルホン酸
JPH07603B2 (ja) * 1987-02-27 1995-01-11 北陸製薬株式会社 イソキノリンスルホンアミド誘導体

Also Published As

Publication number Publication date
NL193726B (nl) 2000-04-03
SE8904261D0 (sv) 1989-12-19
DK666289D0 (da) 1989-12-22
DK666289A (da) 1990-06-27
KR0183374B1 (ko) 1999-05-01
AT398201B (de) 1994-10-25
NL193726C (nl) 2000-08-04
CA2005741A1 (en) 1990-06-26
FR2640973B1 (de) 1992-03-27
GB2228933B (en) 1993-03-31
GB2228933A (en) 1990-09-12
US5081246A (en) 1992-01-14
NL8903143A (nl) 1990-07-16
CH680441A5 (de) 1992-08-31
DK175678B1 (da) 2005-01-17
ES2029759A6 (es) 1992-09-01
CA2005741C (en) 1998-06-02
FR2640973A1 (de) 1990-06-29
GB8928895D0 (en) 1990-02-28
SE503081C2 (sv) 1996-03-18
KR900009598A (ko) 1990-07-05
SE8904261L (sv) 1990-06-27

Similar Documents

Publication Publication Date Title
ATA293589A (de) Neue chinolinsulfonaminoderivate und verfahren zu deren herstellung sowie pharmazeutische zusammensetzung
ATA315488A (de) Neue adenosinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische praeparate
ATA256092A (de) Aminosäurederivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATE187167T1 (de) Amido-3-pyrazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
ATA125988A (de) Pharmazeutische cefuroximaxetil-zusammensetzung und verfahren zu ihrer herstellung
ATA176789A (de) Intravenös anwendbare pharmazeutische präparate und verfahren zu ihrer herstellung
ATE307576T1 (de) Fenofibrathaltige arzneizusammensetzung mit erhöhter bioverfügbarkeit und verfahren zu deren herstellung
DE58904479D1 (de) Pharmazeutische zubereitung sowie verfahren zu ihrer herstellung.
FI892718A7 (fi) Menetelmä alkoholismin hoidossa käytettävien farmaseuttisten koostumusten valmistamiseksi
DE3680578D1 (de) Dipeptid-derivate, verfahren zur herstellung, pharmazeutische zusammensetzungen und ihre anwendung.
ATA900894A (de) Pharmazeutische kompositionen zum vorbeugen und heilen von krebserkrankungen und verfahren zu ihrer herstellung
KR900700492A (ko) N-헤테로사이클릭 프로필리덴-1,1-비스포스폰산, 이의 제조방법 및 약제학적 조성물
ATA247489A (de) Festes pharmazeutisches piroxicam-präparat und verfahren zu seiner herstellung
ATE143010T1 (de) Pyridazin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE3777122D1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE194616T1 (de) Substituierte 4-phenyl-thiazole derivate, verfahren zu deren herstellung und pharmazeutische zusammenstellungen die sie enthalten
ATA56790A (de) Thieno-triazolo-diazepinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
ATA95690A (de) Thieno-triazolo-diazepinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
DE3675714D1 (de) Substituierte hexahydroarylchinolizinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATA260590A (de) Glyzerinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
DE68910523D1 (de) Trizyklische 3-oxo-propannitril-derivate und verfahren zu deren herstellung.
ATA328587A (de) Neue furanuronsaeure-derivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
DE3852332D1 (de) 4-Thiochinazolin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammenstellungen.
ATA98794A (de) Verfahren zur herstelung von teilchen, so erhaltene teilchen und solche teilchen enthaltende pharmazeutische massen
DE3767894D1 (de) 1,2-dithiol-3-thion-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee